Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege. - Wikidata - wikimedia - TriplyDB

Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege.

Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege.

http://www.wikidata.org/entity/Q33985624

about

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly Human cytomegalovirus infection of human adipose-derived stromal/stem cells restricts differentiation along the adipogenic lineage.Activity of mesenchymal stem cells in therapies for chronic skin wound healing.Stem cell therapy for cardiac regeneration: hits and misses.Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+ T-Cell Cultures.Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.Effect of Local Anesthetics on Human Mesenchymal Stromal Cell Secretion Collagen-Based Medical Device as a Stem Cell Carrier for Regenerative Medicine.Comparative Analysis of Human Adipose-Derived Mesenchymal Stem Cells from Orbital and Abdominal Fat

P2860

Q33746687-EAADC174-4E7A-48BB-AF95-0AD83F6A3293 Q36812379-06EE1106-DE37-4D6B-8509-D1B158CEAE6C Q38169955-C0FB90D7-F5F1-4FAE-9C74-3A0AC2C3B93C Q38601272-C5D3917C-EBA8-4AD7-B0E1-C9E9EC7960C1 Q38831977-CD862998-BD32-4F1E-9D85-E3B1EA42F485 Q39150444-E07ADBF1-E295-4C04-AEA4-7A98F64A1BF3 Q42119570-CE02945C-B1EB-43C5-B4BB-65F064C430FB Q42517370-EA5F2B8A-3BD9-4A8C-9FB3-E16EEA3D7D0B Q58766215-78867AAE-3FB0-40AE-84F7-45190A134EB8

P2860

Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege.

http://www.wikidata.org/entity/Q33985624

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@ast

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@en

type

label

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@ast

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@en

prefLabel

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@ast

Interleukin-6 downregulation w ...... ts in loss of immunoprivilege.

@en

P1433

Q33985624-C55C2187-7FEF-4FB9-B3D6-30B5F7E924CB

P1476

Q33985624-6BF9E151-502A-47E8-A221-A6097D08220A

P2093

Q33985624-372C669B-E67E-481A-958B-E1B9E57A6297

Q33985624-4108C9D6-6D87-425D-B32D-A1A3E4DDD47C

Q33985624-47431F1F-C49A-4040-B921-1E8D71BF5414

Q33985624-C7C4C33A-17F7-4BAD-ADFE-735B8A8DD408

Q33985624-CFE2CF1C-46AD-4879-AB9D-5005E3C38199

Q33985624-E08A55D5-8A13-40A9-8135-4907652B19A1

Q33985624-F2E93DDC-EAAF-4F54-8235-B0A53AB57899

P2860

Q33985624-0B824FAD-B8DF-4CF9-8EDC-A97ED311058F

Q33985624-119B1A97-1147-4F82-B485-2D1713205B2E

Q33985624-231FF6BE-D6CC-41BC-9864-93E2924F295C

Q33985624-2A4D7727-A92B-4779-8036-7B48B0286D28

Q33985624-447DFBBD-135C-4D9B-91E9-7A885E7FD7EE

Q33985624-5141B7E3-C08D-49EC-B0DF-164DE8E963E7

Q33985624-58F2DF7F-D78A-41EC-A04B-E9415618FDFB

Q33985624-5B9F3073-0B97-4A11-8452-A5C0083B1C3A

Q33985624-7562EC23-F3B9-4325-8AD8-54D7428047EB

Q33985624-8A6AC940-F72B-4ED5-BE42-634618D62433

P304

Q33985624-71BBC34B-4E8D-47E9-B189-B23B5E4C1041

P31

Q33985624-9E302E48-539B-4917-818A-6922E062E1B3

P356

Q33985624-34D7939C-9E49-4F50-A4EF-A714856CC34A

P433

Q33985624-0CB5D0E7-D323-4CE9-9E05-35D2A8F622E9

P478

Q33985624-C70F08B5-E577-4335-B14B-38B902301F4D

P50

Q33985624-8F045A45-2833-4D7C-B011-269B097653DD

P577

Q33985624-4740C867-1EF5-4CC5-9382-06E9F38F24DD

P5875

Q33985624-3CB6BD4F-7AE3-4AE9-8ED7-1CA1F226B54E

P698

Q33985624-CB65CE52-27C7-4183-856F-6850EAFCFECB

P932

Q33985624-83D9BFDE-3890-4E1D-A8B8-8C9F17C8895F

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Interleukin-6 downregulation w ...... lts in loss of immunoprivilege

@en

P2093

Jun Wu

http://www.w3.org/2001/XMLSchema#string

Lu Sun

http://www.w3.org/2001/XMLSchema#string

Peng Li

http://www.w3.org/2001/XMLSchema#string

Ren-Ke Li

http://www.w3.org/2001/XMLSchema#string

Richard D Weisel

http://www.w3.org/2001/XMLSchema#string

Shu-Hong Li

http://www.w3.org/2001/XMLSchema#string

Wang-Fu Zang

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

Human mesenchymal stem cells modulate allogeneic immune cell responses

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Cytokine secretion profiling of human mesenchymal stem cells by antibody array.

IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis

Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.

Mesenchymal stem cells and their potential as cardiac therapeutics.

Cardiac remodeling and failure: from molecules to man (Part I).

P304

1136-1145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12092

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242331956

http://www.w3.org/2001/XMLSchema#string

P698

23802625

http://www.w3.org/2001/XMLSchema#string

P932

4118173

http://www.w3.org/2001/XMLSchema#string